Synchron Raises $200 Million Series D to Advance Brain-Computer Interface Technology
Synchron has announced the successful completion of a $200 million Series D funding round aimed at accelerating the development and commercialization of its groundbreaking Stentrode™ brain-computer interface (BCI) platform.
The funding will enable the company to expand its artificial intelligence and engineering operations across its New York and San Diego facilities, enhancing its ability to bring next-generation neurotechnology to market.
Photo credit: Synchron
For media inquiries, contact Kimberly Ha at [email protected].
Author’s Summary
Synchron secures major funding to accelerate its Stentrode™ BCI platform and expand AI-driven technology development in the U.S.